Skip to main content
Article thumbnail
Location of Repository

Bioidentical Hormones for Menopausal Hormone Therapy: Variation on a Theme

By Adriane Fugh-Berman and Jenna Bythrow
Topics: Perspectives
Publisher: Springer-Verlag
OAI identifier: oai:pubmedcentral.nih.gov:2219716
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. A clinical trial of estrogen-replacement therapy after ischemic stroke.
    2. A study to evaluate serum and urinary hormone levels following short and long term administration of two regimens of progesterone cream in postmenopausal women.
    3. A study to look at hormonal absorption of progesterone cream used in conjunction with transdermal estrogen.
    4. Ageless: the naked truth about bioidentical hormones.
    5. (2005). Available at http://drerika.com/EN/index.html.
    6. (2004). Available at http://medxlife.com/getArticles.asp?aId=54& categoryId=10.
    7. (2005). Available at http://premier-pharmacy.com/ abouthrt3.html. Accessed
    8. (2005). Available at http://www.altmednetwork.net/whealth/ progest_crm.html. Accessed
    9. (2005). Available at http://www.collegepharmacy.com/ specializations/biest.asp. Accessed
    10. (2005). Available at http://www.pureessencelabs.com/pdf/ femcreme.pdf. Accessed
    11. (2006). Available via the internet at http://www.
    12. (1997). Biochemical and histological effects of vaginal estriol and estradiol applications on the endometrium, myometrium and vagina of postmenopausal women. Gynecol Endocrinol.
    13. Bioidentical hormone therapy: a review.
    14. Bleeding profiles and effects on the endometrium for women using a novel combination of transdermal oestradiol and natural progesterone cream as part of a continuous combined hormone replacement regime.
    15. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.
    16. (2000). but not serum or urinary levels of progesterone are elevated after topical application of progesterone cream to pre- and postmenopausal women. Clin Endocrinol.
    17. Caution on the use of saliva measurements to monitor absorption of progesterone from transdermal creams in postmenopausal women.
    18. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women’s Health Initiative: a randomized trial.
    19. Effects of estrogen plus progestin on health-related quality of life.
    20. Effects of estrogen with and without progestin on urinary incontinence.
    21. Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.
    22. Endogenous Hormones Breast Cancer Collaborative Group. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.
    23. Endometrial sonography and histological findings in women with and without hormonal replacement therapy suffering from post menopausal bleeding.
    24. ESPRIT team. Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial.
    25. et al.,WHI Investigators. Effects of conjugated equine estrogen on stroke in the Women’s Health Initiative.
    26. (2007). Hormones and the woman’s life cycles. Available at http:// www.drhotze.com/EN/online_articles/389.html. Accessed
    27. (2004). Investigation of product quality between extemporaneously compounded progesterone vaginal suppositories and an approved progesterone vaginal gel. Drug Dev Ind Pharm.
    28. Low-potency oestrogen and risk of endometrial cancer: a case-control study.
    29. (1999). Micronised transdermal progesterone and endometrial response. Lancet
    30. (1993). Natural Progesterone: The Multiple Roles of a Remarkable Hormone.
    31. Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomized placebo controlled trial.
    32. Over-the-counter progesterone cream produces significant drug exposure compared to a Food and Drug Administration approved oral progesterone.
    33. (1980). Pathophysiologic considerations in the treatment of menopausal patients with oestrogens; the role of oestriol in the prevention of mammary carcinoma. Acta Endocrinol Suppl (Copenh).
    34. Percutaneous absorption of progesterone in postmenopausal women treated with transdermal estrogen.
    35. Percutaneous administration of progesterone: blood levels and endometrial protection.
    36. (2002). Pharmacy. Especially Designed for Women.
    37. (1998). Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.
    38. Plasma sex steroid hormones and breast cancer risk in Chinese women.
    39. (2003). Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden). Cancer Causes Control.
    40. Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study.
    41. (2000). Sex steroid hormones in serum and tissue of benign and malignant breast tumor patients. Dis Markers.
    42. ShumakerSA,LegaultC,RappSR,etal.,WHIMSInvestigators.Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial.
    43. Steroids, the steroid community, and Upjohn in perspective: a profile of innovation.
    44. Systemic absorption of progesterone from Progest cream in postmenopausal women.
    45. (2003). The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells. Life Sci.
    46. The effects of oral estriol on the endometrium in postmenopausal women.
    47. The effects of oral estriol on the endometrium in postmenopausaul women.
    48. (2003). Topical progesterone cream has an antiproliferative effect on estrogen-stimulated endometrium. Fertil Steril.
    49. Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women.
    50. (1999). Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol.
    51. Urinary endogenous sex hormone levels and the risk of postmenopausal breast cancer.
    52. (2002). What Your Doctor May Not Tell You About Breast Cancer! How Hormone Balance Can Help Save Your Life.
    53. (2004). What Your Doctor May Not Tell You About Menopause: The Breakthrough Book on Natural Progesterone.
    54. Women’s beliefs about “natural” hormones and natural hormone replacement therapy.
    55. Women’s Health Initiative Memory Study. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women’s Health Initiative Memory Study.
    56. Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial.
    57. Writing group for the Women’s Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.